Company Overview of CorePharma, L.L.C.
CorePharma, L.L.C. develops, manufactures, and markets generic and branded prescription pharmaceuticals in the United States. The company offers its products in various dosage forms, such as oral tablets, capsules, and pellet dosages, as well as in various therapeutic categories. It manages a portfolio of high barrier-to-entry products that include controlled substances, which include Schedule-II, -III, –IV, and –V drugs; and modified release formulations. The company was founded in 1998 and is based in Middlesex, New Jersey. CorePharma, L.L.C. operates as a subsidiary of Impax Laboratories Inc.
215 Wood Avenue
Middlesex, NJ 08846
Founded in 1998
Key Executives for CorePharma, L.L.C.
Similar Private Companies By Industry
|1st Order Pharmaceuticals, Inc.||United States|
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact CorePharma, L.L.C., please visit www.corepharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.